Content

Cancer scenario 2015, Guwahati.

Saturday, 13th June 2015, 7:00 pm at Hotel Radisson Blu, Guwahati

Genitourinary Cancer

cancer specialist bladder cancer kidney cancer prostrate cancer reproductive organ cancer dr feroz pasha

Genitourinary cancers affect organs in the urinary tracts of men and women, such as the bladder and kidneys, as well as the male reproductive organs of the prostate and testes.

Prostate cancer is usually adenocarcinoma. Symptoms are usually absent until tumor growth causes hematuria and/or obstruction with pain.

At Onkaulogy Kombine, we offer multidisciplinary diagnosis and treatment of patients with cancer of the prostate, bladder, testes or kidney. Our leading oncologists, urological surgeons, radiation oncologists, radiologists and pathologists provide the best diagnosis and management for genitourinary cancers. Treatment includes:

  • Minimally invasive surgical techniques, including nerve-sparing prostatectomy, partial or laparoscopic nephrectomy for renal cancer.
  • Radioactive seed implant brachytherapy for prostate cancer.
  • Radiofrequency ablation for renal masses.
  • Bladder-sparing operations and orthotopic diversion for bladder cancer.
  • Watchful waiting strategies for prostate cancer.

Our goal is to effectively treat prostate cancer while improving quality of life among our patients and their spouses or partners.

Symptoms:
Prostate cancer usually progresses slowly and rarely causes symptoms until advanced. In advanced disease, hematuria and symptoms of bladder outlet obstruction may appear. This may be straining, hesitancy, weak or intermittent urine stream, a sense of incomplete emptying and/or terminal dribbling.

Diagnosis:

  • Screening by digital rectal examination and prostate-specific antigen
    Most cancers today are found by screening with serum prostate-specific antigen (PSA) levels (and sometimes DRE). Screening is commonly done annually in men > 50 years but is sometimes begun earlier for men at high risk (eg, those with a family history of prostate cancer and black men). Abnormal findings are further investigated with biopsy
  • Assessment of abnormalities by transrectal needle biopsy
  • Grading by histology
    Grading, based on the resemblance of tumor architecture to normal glandular structure, helps define the
  • aggressiveness of the tumor.
  • Staging by CT and bone scanning

Treatment:

Depending on whether the cancer is within prostate or outside, treatment can vary from surgery and radiation therapy for localised cancer and palliation with radiation or chemotherapy for others.

Treatment is guided by PSA level, grade and stage of tumor, patient age, coexisting disorders, and life expectancy.

  • Local therapy is aimed at curing prostate cancer and may thus also be called definitive therapy. Radical prostatectomy, some forms of radiation therapy, and cryotherapy are options. Careful counseling concerning the risks and benefits of these treatments and considerations of patient-specific characteristics like age and healthare critical in decision making.
  • Brachytherapy involves the implantation of radioactive seeds into the prostate through the perineum. These seeds emit a burst of radiation over a finite period and are then inert.
  • Systemic therapies If cancer has spread beyond the prostate gland, cure is unlikely; systemic treatment aimed at decreasing or limiting tumor extent is usually given.

Diagnosis:

  • Screening by digital rectal examination and prostate-specific antigen
    Most cancers today are found by screening with serum prostate-specific antigen (PSA) levels (and sometimes DRE). Screening is commonly done annually in men > 50 years but is sometimes begun earlier for men at high risk (eg, those with a family history of prostate cancer and black men). Abnormal findings are further investigated with biopsy
  • Assessment of abnormalities by transrectal needle biopsy
  • Grading by histology
    Grading, based on the resemblance of tumor architecture to normal glandular structure, helps define the
  • aggressiveness of the tumor.
  • Staging by CT and bone scanning

Treatment:

Depending on whether the cancer is within prostate or outside, treatment can vary from surgery and radiation therapy for localised cancer and palliation with radiation or chemotherapy for others.

Treatment is guided by PSA level, grade and stage of tumor, patient age, coexisting disorders, and life expectancy.

  • Local therapy is aimed at curing prostate cancer and may thus also be called definitive therapy. Radical prostatectomy, some forms of radiation therapy, and cryotherapy are options. Careful counseling concerning the risks and benefits of these treatments and considerations of patient-specific characteristics like age and healthare critical in decision making.
  • Brachytherapy involves the implantation of radioactive seeds into the prostate through the perineum. These seeds emit a burst of radiation over a finite period and are then inert.
  • Systemic therapies If cancer has spread beyond the prostate gland, cure is unlikely; systemic treatment aimed at decreasing or limiting tumor extent is usually given.